First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
Active, not recruiting · NCT06410313 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease | Popliteal Artery Stenosis; Superficial Femoral Artery Stenosis | Active, not recruiting | Not applicable | 2026-10-09 | NCT06410313 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medinol Ltd. | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Medical Center/ NewYork Presbyterian Hospital or CUMC/NYPH | New York | United States | 2 |
| Piedmont Healthcare, Inc. | Atlanta | United States | 2 |
| Royal North Shore Hospital | Sydney | Australia | 6 |
| Royal Perth Hospital | Perth | Australia | 7 |
| Royal Prince Alfred Hospital | Sydney | Australia | 6 |
| St Francis Hospital Heart Center | Roslyn | United States | 1 |
| The Alfred Hospital | Melbourne | Australia | 12 |